Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
- DOI
- 10.1016/s1474-4422(08)70198-4
- Published
- 2008 Oct
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-08-70198-4,
title = {Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.},
author = {Diener HC and Sacco RL and Yusuf S and Cotton D and Ounpuu S and Lawton WA and Palesch Y and Martin RH and Albers GW and Bath P and Bornstein N and Chan BP and Chen ST and Cunha L and Dahlöf B and De Keyser J and Donnan GA and Estol C and Gorelick P and Gu V and Hermansson K and Hilbrich L and Kaste M and Lu C and Machnig T and Pais P and Roberts R and Skvortsova V and Teal P and Toni D and VanderMaelen C and Voigt T and Weber M and Yoon BW and Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group},
year = {2008},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(08)70198-4},
url = {https://doi.org/10.1016/s1474-4422(08)70198-4}
}RIS
TY - JOUR TI - Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. AU - Diener HC AU - Sacco RL AU - Yusuf S AU - Cotton D AU - Ounpuu S AU - Lawton WA AU - Palesch Y AU - Martin RH AU - Albers GW AU - Bath P AU - Bornstein N AU - Chan BP AU - Chen ST AU - Cunha L AU - Dahlöf B AU - De Keyser J AU - Donnan GA AU - Estol C AU - Gorelick P AU - Gu V AU - Hermansson K AU - Hilbrich L AU - Kaste M AU - Lu C AU - Machnig T AU - Pais P AU - Roberts R AU - Skvortsova V AU - Teal P AU - Toni D AU - VanderMaelen C AU - Voigt T AU - Weber M AU - Yoon BW AU - Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group PY - 2008 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(08)70198-4 UR - https://doi.org/10.1016/s1474-4422(08)70198-4 ER -
APA
HC, D., RL, S., S, Y., D, C., S, O., WA, L., Y, P., RH, M., GW, A., P, B., N, B., BP, C., ST, C., L, C., B, D., J, D. K., GA, D., C, E., P, G., V, G., K, H., L, H., M, K., C, L., T, M., P, P., R, R., V, S., P, T., D, T., C, V., T, V., M, W., BW, Y., & group, P. R. F. E. A. S. S. (. S. (2008). Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(08)70198-4
Source records
- pubmed · retrieved 2026-09-26T23:09:00.657Z